SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-044412
Filing Date
2017-08-21
Accepted
2017-08-21 16:37:12
Documents
66
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v473640_10q.htm 10-Q 547682
2 EXHIBIT 10.1 v473640_ex10-1.htm EX-10.1 31260
3 EXHIBIT 31.1 v473640_ex31-1.htm EX-31.1 9129
4 EXHIBIT 32.1 v473640_ex32-1.htm EX-32.1 4032
  Complete submission text file 0001144204-17-044412.txt   6620183

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nwbo-20170630.xml EX-101.INS 1695425
6 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20170630.xsd EX-101.SCH 58834
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20170630_cal.xml EX-101.CAL 38804
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20170630_def.xml EX-101.DEF 444557
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20170630_lab.xml EX-101.LAB 411391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20170630_pre.xml EX-101.PRE 461758
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 171043433
SIC: 2834 Pharmaceutical Preparations